Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.

about

Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.

Item

http://www.wikidata.org/entity/Q39119013

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.

@en

Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.

@nl

type

Item

label

Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.

@en

Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.

@nl

prefLabel

Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.

@en

Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.

@nl

P1476

Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.

@en

P2093

Donald N Di Salvo

http://www.w3.org/2001/XMLSchema#string

Jyothi P Jagannathan

http://www.w3.org/2001/XMLSchema#string

Katherine M Krajewski

http://www.w3.org/2001/XMLSchema#string

Marta Braschi-Amirfarzan

http://www.w3.org/2001/XMLSchema#string

Nikhil H Ramaiya

http://www.w3.org/2001/XMLSchema#string

Sree Harsha Tirumani

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical problem solving: utility of sonography in oncologic patients

Diffuse gallbladder wall thickening: differential diagnosis

Drug-induced pancreatitis: an update.

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography.

Drug-related hepatotoxicity.

Sunitinib in patients with metastatic renal cell carcinoma.

The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors.

Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab.

Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective.

P2888

s00261-017-1050-6

P304

1721-1733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00261-017-1050-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Alessandrino

P577

2017-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28160038

http://www.w3.org/2001/XMLSchema#string